← Every company
Intellia Therapeutics Inc SEC Filings
What Intellia Therapeutics Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
NTLA overview →Filings on file
140
since Nov 1, 2016
Warning signs
0
none filed
Last results
Aug 6, 2026
8-K item 2.02
Industry
In Vitro & In Vivo Diagnostic Substances
SIC 2835
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Aug 7, 2025 | Executive or director changeResults announced 8-K | Read ↗ |
| Jun 12, 2025 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Jan 10, 2025 | Executive or director changeResults announcedRestructuring 8-K | Read ↗ |
| Jun 26, 2024 | Executive or director change 8-K | Read ↗ |
| Jun 14, 2024 | Executive or director change 8-K | Read ↗ |
| Apr 15, 2024 | Executive or director change 8-K | Read ↗ |
| Dec 6, 2023 | Executive or director change 8-K | Read ↗ |
| Jun 5, 2023 | Executive or director change 8-K | Read ↗ |
| Apr 17, 2023 | Executive or director change 8-K | Read ↗ |
| Mar 24, 2023 | Executive or director change 8-K | Read ↗ |
| May 3, 2022 | Executive or director change 8-K | Read ↗ |
| Jun 22, 2021 | Executive or director change 8-K | Read ↗ |
| Apr 12, 2021 | Executive or director change 8-K | Read ↗ |
| Oct 5, 2020 | Executive or director change 8-K | Read ↗ |
| Jan 24, 2019 | Executive or director change 8-K | Read ↗ |
| Oct 31, 2018 | Executive or director changeResults announced 8-K | Read ↗ |
| Oct 29, 2018 | Executive or director change 8-K | Read ↗ |
| Jun 22, 2018 | Executive or director change 8-K | Read ↗ |
| Apr 17, 2018 | Executive or director change 8-K | Read ↗ |
| Dec 18, 2017 | Executive or director change 8-K | Read ↗ |
| Sep 1, 2017 | Executive or director change 8-K | Read ↗ |
| Aug 8, 2017 | Executive or director change 8-K | Read ↗ |
| Jul 25, 2017 | Executive or director change 8-K | Read ↗ |
| Dec 13, 2016 | Executive or director change 8-K | Read ↗ |
| Nov 4, 2016 | Executive or director change 8-K | Read ↗ |
Source: Intellia Therapeutics Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on NTLA
Company overviewEverything on NTLA in one place, with the price.Insider tradingWhat NTLA's own officers and directors buy and sell.Planned salesSales NTLA insiders have filed notice of.Executive payWhat NTLA awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in NTLA.Funds holding itWhich funds and ETFs hold NTLA, and how big a bet.PatentsWhat NTLA is filing at the patent office.